Ceftin

Dosaggio del prodotto: 125 mg
Confezione (n.)Per compressePrezzoAcquista
10€3.22€32.24 (0%)🛒 Aggiungi al carrello
30€3.20€96.71 €95.86 (1%)🛒 Aggiungi al carrello
60
€2.71 Migliore per compresse
€193.42 €162.88 (16%)🛒 Aggiungi al carrello
90€2.74€290.13 €246.86 (15%)🛒 Aggiungi al carrello
Dosaggio del prodotto: 250mg
Confezione (n.)Per compressePrezzoAcquista
30€3.93€117.92 (0%)🛒 Aggiungi al carrello
60€3.10€235.83 €185.78 (21%)🛒 Aggiungi al carrello
90€2.81€353.75 €252.80 (29%)🛒 Aggiungi al carrello
120
€2.67 Migliore per compresse
€471.67 €319.82 (32%)🛒 Aggiungi al carrello
Dosaggio del prodotto: 500mg
Confezione (n.)Per compressePrezzoAcquista
30€5.43€162.88 (0%)🛒 Aggiungi al carrello
60€4.09€325.76 €245.17 (25%)🛒 Aggiungi al carrello
90
€3.64 Migliore per compresse
€488.63 €327.45 (33%)🛒 Aggiungi al carrello
Sinonimi

Prodotti simili

Ceftin (Cefuroxime Axetil): Oral Cephalosporin Therapy for Respiratory and Skin Infections – A Clinical Re-Evaluation

So, Ceftin. GlaxoSmithKline’s old workhorse. Cefuroxime axetil. I’ve been prescribing this stuff for almost two decades now, and honestly? It’s one of those drugs that doesn’t get the respect it deserves anymore. Everyone jumps straight to the respiratory fluoroquinolones or the macrolides—especially azithromycin, that three-day Z-pak magic—but they forget that Ceftin still punches hard for a specific set of bugs. Let’s walk through it, clinically.

What Is Ceftin? Defining the Product in Context

Ceftin is the oral prodrug formulation of cefuroxime, a second-generation cephalosporin. You give the axetil ester, it gets hydrolyzed in the intestinal mucosa and portal circulation, and you end up with active cefuroxime in the serum. The key here is that it’s not a first-generation like cephalexin (Keflex) and it’s not a third-generation like cefdinir (Omnicef). It sits in that sweet middle spot.

The original FDA approval was back in the late 80s. I remember seeing the first NDA data—it was a big deal because it was one of the first oral cephalosporins that actually had decent coverage against Haemophilus influenzae and Moraxella catarrhalis, including the beta-lactamase producers. Before that, we were stuck with amoxicillin and hoping for the best.

Composition and Bioavailability: The Axetil Advantage

The drug comes as 250 mg and 500 mg tablets, plus a suspension for kids. The suspension is a nightmare, by the way—tastes like bitter chalk and burnt sugar. Parents hate it. But the tablets? They’re fine.

Bioavailability is around 30-50% when taken on an empty stomach, but here’s the clinical pearl: take it with food. Food increases absorption significantly, up to 60-70%. I’ve had residents argue with me about this—they read the package insert and see the standard “take without regard to meals”—but the data is clear. A fatty meal boosts the AUC by about 30%. So I tell patients: take it with breakfast or dinner.

The axetil moiety is lipophilic, which helps with gut penetration. But it also means the drug is unstable in aqueous solution—hence the tablet form. You can’t crush and mix it into juice easily. That’s a problem for elderly patients with dysphagia. I’ve had to switch to cefdinir more than once just because the patient couldn’t swallow the horse pill.

Mechanism of Action: Why It Still Works (When It Works)

Ceftin works like all beta-lactams: it binds to penicillin-binding proteins (PBPs), specifically PBP-3 in many gram-negatives, and inhibits transpeptidation during cell wall synthesis. The cell wall gets weak, the autolytic enzymes kick in, and the bacteria lyse.

But here’s the nuance. Ceftin is more resistant to beta-lactamases than first-generation cephalosporins because of the methoxyimino group on the side chain. That’s the “cefuroxime” structural feature. It’s not as stable as the third-generation drugs against extended-spectrum beta-lactamases (ESBLs)—don’t even think about using it for an ESBL E. coli—but for the common respiratory pathogens, it’s fine.

The time-dependent killing is critical. You need the serum concentration above the MIC for at least 40-50% of the dosing interval. That’s why we dose it twice daily, not once. I’ve seen colleagues try to BID it for sinusitis and then wonder why the patient comes back with persistent symptoms. You need consistent levels.

Indications for Use: Where Ceftin Shines

I’ve used Ceftin for four main indications over the years, and I’ve got the battle scars to prove it.

Acute Bacterial Sinusitis

This is probably the most common reason I reach for Ceftin. The big three pathogens are Streptococcus pneumoniae, H. influenzae, and M. catarrhalis. Ceftin covers all three, including the beta-lactamase producers. The clinical trials from the early 2000s showed about 85% clinical cure rates at 10-14 days. I had a patient, Mark, 42-year-old accountant, who came in with three weeks of facial pressure, green discharge, and fever. He’d already failed amoxicillin. I put him on Ceftin 250 mg BID for 10 days. Day 4, he called me—first time he’d slept through the night in two weeks.

Acute Otitis Media (AOM)

Kids. Oh, kids. The suspension is terrible, but the efficacy is real. The AOM guidelines from the AAP still list cefuroxime as a second-line option after amoxicillin failure. The typical dose is 30 mg/kg/day divided BID. I’ve had mixed results with the suspension—some kids tolerate it, others spit it out. But if you can get them to take it, it works. I remember a 3-year-old, Sarah, who had recurrent AOM. She’d been on amoxicillin three times in six months. Ceftin cleared it. Her mom was thrilled. I was thrilled.

Lyme Disease (Early Localized or Early Disseminated)

This is a niche but important use. For patients who can’t take doxycycline—pregnant women, kids under 8—cefuroxime is an alternative. The data from the clinical trials in the 1990s showed equivalent efficacy to doxycycline for erythema migrans. I’ve used it maybe a dozen times. It works. But you need to treat for 14-21 days. And the patient has to understand that it’s not as convenient as doxycycline BID.

Secondary Bacterial Infections in Acute Bronchitis

The IDSA guidelines say don’t use antibiotics for acute bronchitis unless you suspect pertussis or there’s a clear bacterial superinfection. But in practice, I’ve used Ceftin when the cough has been productive for more than 10 days with purulent sputum and the patient has a history of COPD. It’s off-label for this, but the coverage is reasonable.

Instructions for Use: Dosing and Practical Administration

Here’s the table I use in my clinic:

IndicationAdult DosePediatric DoseDuration
Sinusitis250 mg BID30 mg/kg/day10-14 days
Otitis MediaN/A30 mg/kg/day10 days
Lyme Disease500 mg BID30 mg/kg/day14-21 days
Skin Infections250-500 mg BID30 mg/kg/day7-10 days

Important: Always take with food. If the patient misses a dose, take it as soon as remembered unless it’s almost time for the next dose. Don’t double up.

Side effects: Diarrhea is the most common—about 5-10% of patients. I’ve had a few cases of C. diff colitis, but it’s rare. The drug can also cause a false-positive for glucose in urine if you’re using copper reduction tests (Clinitest). That’s a classic pearl from medical school. Don’t get caught.

Contraindications and Drug Interactions

Absolute contraindication: Known hypersensitivity to cephalosporins or severe penicillin allergy (anaphylaxis). The cross-reactivity rate is about 5-10% for immediate-type reactions. For non-severe penicillin allergies, it’s usually safe, but I still err on the side of caution.

Relative contraindication: Renal impairment. Ceftin is primarily excreted renally. For CrCl < 30 mL/min, you need to adjust the dosing interval to every 24 hours. I’ve forgotten this once. Patient with CKD stage 4, I gave standard BID dosing for sinusitis. She developed neurotoxicity—confusion, myoclonus. It resolved after holding the drug. But it scared me.

Drug interactions: Probenecid increases cefuroxime levels (inhibits tubular secretion). Oral anticoagulants? Theoretically, cephalosporins can potentiate warfarin by killing gut flora that synthesize vitamin K. I’ve seen it happen twice. Monitor INR closely.

Pregnancy and lactation: Category B. No evidence of harm in animal studies. I’ve used it in pregnant women with Lyme disease. No issues.

Clinical Studies and Evidence Base

Let’s talk about the data that actually matters.

The pivotal trial for Ceftin in sinusitis was a multicenter, randomized, double-blind study comparing cefuroxime axetil 250 mg BID to amoxicillin/clavulanate 500/125 mg TID. The clinical cure rate was 85% vs. 82%—statistically non-inferior. But the tolerability was better with Ceftin. Less diarrhea. That’s why I prefer it.

For otitis media, the Cochrane review from 2015 analyzed 13 trials. Cefuroxime had a clinical success rate of about 80% at 10-14 days, comparable to amoxicillin/clavulanate. But the suspension taste compliance was a significant confounder. The reviewers noted that “taste acceptability may influence real-world effectiveness.”

For Lyme disease, the study by Luft et al. in Annals of Internal Medicine (1996) randomized 123 patients with erythema migrans to either cefuroxime 500 mg BID or doxycycline 100 mg BID for 20 days. The cure rates were 88% and 90%, respectively. No significant difference. That’s the study I cite when talking to skeptical colleagues.

But here’s the thing I’ve learned that the trials don’t show: Ceftin works best when you catch the infection early. If the patient has been symptomatic for more than 10 days with sinusitis, the biofilm formation is already happening. Ceftin doesn’t penetrate biofilms well. I’ve had failures in chronic sinusitis patients. The drug is for acute, not chronic.

Comparing Ceftin with Similar Products

People ask me all the time: “Should I use Ceftin or cefdinir?” Here’s my take.

Cefdinir (Omnicef) is a third-generation cephalosporin. It has better gram-negative coverage, including E. coli and Klebsiella. But it’s also more expensive and has a higher rate of GI side effects. For sinusitis and otitis media, the two are essentially interchangeable. I use Ceftin because it’s cheaper and I’ve had good results.

Cefpodoxime (Vantin) is another second-generation. It’s dosed once daily, which is nice. But the absorption is more variable. Ceftin has more predictable pharmacokinetics.

Amoxicillin/clavulanate (Augmentin) is the direct competitor. It covers anaerobes better—important for dental infections and aspiration pneumonia. But it causes more diarrhea. Ceftin is cleaner for the gut.

My personal algorithm: For uncomplicated sinusitis in a non-allergic adult, I start with Ceftin. If they fail, I go to a respiratory fluoroquinolone (levofloxacin or moxifloxacin) or a higher-generation cephalosporin. But I try to avoid fluoroquinolones because of the tendon and CNS risks.

Frequently Asked Questions (Clinical Pearls)

Ten to fourteen days. I usually do 10 for mild cases, 14 for moderate to severe. If the patient is still symptomatic after 7 days, I switch.

Can Ceftin be combined with other antibiotics?

Rarely. I’ve combined it with metronidazole for anaerobic coverage in mixed infections. But generally, monotherapy is preferred.

Is Ceftin effective against MRSA?

Absolutely not. Zero coverage. Don’t even think about it.

Can Ceftin be used for UTIs?

Technically yes, but it’s not first-line. The drug concentrates well in urine, but the MICs for E. coli are higher than for respiratory pathogens. I’ve used it for uncomplicated cystitis in patients with penicillin allergy. It works, but nitrofurantoin or TMP-SMX is better.

Conclusion: Validity of Ceftin in Modern Practice

Look, Ceftin is not a sexy drug. It’s not going to cure sepsis or cover Pseudomonas. But for the bread-and-butter respiratory infections—sinusitis, otitis media, acute exacerbations of chronic bronchitis—it’s reliable, well-tolerated, and evidence-based.

The biggest challenge I face now is antimicrobial resistance. I’ve seen S. pneumoniae with intermediate resistance to cefuroxime (MIC 2-4 mcg/mL). The clinical breakpoints have changed over the years. For sinusitis, the CLSI breakpoint for susceptibility is ≤ 1 mcg/mL for S. pneumoniae. That means some strains are now borderline. I check local antibiograms before prescribing.

But for the right patient, at the right dose, with the right duration, Ceftin still delivers.

I had a patient last month, a 60-year-old woman with COPD, recurrent sinusitis. She’d been on azithromycin, then amoxicillin, then levofloxacin. She came to me with green discharge, fever, and facial pain. I did a sinus CT—opacification of the maxillary sinuses. I started her on Ceftin 500 mg BID for 14 days. She called me on day 10. “Doc, I can breathe through my nose for the first time in a month.” That’s why I keep prescribing it.

Final recommendation: Keep Ceftin in your formulary. Use it for acute sinusitis, otitis media, and early Lyme disease. Watch for resistance trends. And for God’s sake, tell patients to take it with food.